Suite 1100 - East Tower
Washington, District Of Columbia 20005
Gordon is a partner in the Life Sciences Health Industry Group, practicing in the area of health care regulatory law. He served as Reed Smith’s life sciences integration partner for the firm’s China offices from 2009-2014. Reed Smith’s offices in Shanghai, Beijing, Hong Kong and Singapore assist pharmaceutical, medical device, health care, and other clients start operations in China, clear regulatory hurdles, and navigate China’s legal and business challenges.
In the United States, Gordon represents device, drug and diagnostic manufacturers on technology reimbursement, to secure coverage, codes, and payment for innovative products. He advises manufacturers on product development linking clinical trials, regulatory approvals, labeling and reimbursement with marketing, sales, and customer support. His experience includes cardiac implants, orthopedic devices, minimally invasive surgical devices, neurology, ophthalmology, diagnostics, imaging, oncology, and other medical specialty areas. He also develops and implements compliance programs under the anti-kickback, fraud and abuse laws.
Within Reed Smith, Gordon served as both co-chair of the firm's Life Sciences Team and Health Care Group practice leader.
|Areas of Practice||1) Health Care, 2) Health Care Fraud and Abuse, 3) Health Care Transactions, 4) Health Care Reimbursement: Coverage, 5) Coding and Payment, 6) Life Sciences Transactions & Regulatory, 7) Life Sciences Reimbursement: Coverage and 8) Coding and Payment|
|Law School||Temple University Beasley School of Law, J.D., 1980|
|Education||Haverford College, B.A., 1974|
|Bar Member / Association||District of Columbia Bar Association, Maryland State Bar Association, Pennsylvania State Bar Association|
|Most recent firm||Reed Smith LLP|
Ms. Fitzgerald represents employers in a wide range of industries, including the entertainment, financial services, hospitality, manufacturing, retail, and transportation industries.
Ms. Shander advises public and private company clients as well as private equity funds, with an emphasis on mergers and acquisitions, dispositions, and financing transactions.